Diabetes-related weight loss drugs facing supply issues amid viral trend
foxbusiness.com
news
2022-10-21 12:19:46

Published October 21, 2022 1:50pm EDT Novo Nordisk — the maker of diabetes-related drugs Ozempic and Wegovy — says its facing supply constraints after the medications rose to popularity on social media amid reports that celebrities were using them to shed excess weight. "We are currently experiencing intermittent supply disruptions on various doses of Ozempic due to the combination of incredible demand coupled with overall global supply constraints," the pharmaceutical company told FOX Business. Meanwhile, the Danish multinational pharmaceutical company says it's also trying to resolve "supply constraints following unprecedented product demand and short-term manufacturing issues" with Wegovy.
